Biovaccines | May & Baker Nigeria Plc

strategic partnership

Biovaccines Nigeria Limited

Biovaccines Nigeria Limited, a strategic partnership with the Federal Government of Nigeria, was incorporated in 2005. The company is owned 51 percent by May & Baker Nigeria Plc. and 49 percent by the Federal Government.

It is a vaccine production and distribution company dedicated to transforming Nigeria's healthcare landscape.

Our Mission & Vision

The objective of Biovaccines Nigeria Limited is to produce safe and affordable human vaccines for Nigeria and reverse the situation of high mortality from immunizable diseases.

It also plans to create a regional center for vaccine production in West Africa and position Nigeria as a global player in the vaccine business.

Incorporated in 2005
51% ownership by May & Baker Nigeria Plc
49% ownership by Federal Government
Vaccine production and distribution
Regional production center for West Africa
Global vaccine business ambition

visit biovaccines website

For more information about Biovaccines Nigeria Limited, visit the company website.

focus areas

Vaccine Production And Distribution

Biovaccines is structured to support vaccine security through production capability, distribution, partnerships and regional public health impact.

Vaccine Production

Developing local capability for safe and affordable human vaccines.

Distribution Support

Supporting access to vaccines through dependable distribution structures.

Public Health Partnership

Working through strategic ownership and partnerships to strengthen immunisation outcomes.

partnership profile

Biovaccines At a Glance

2005

Incorporation year

51%

May & Baker ownership

49%

Federal Government ownership